Form D · Biotechnology

Circular Genomics Inc.

Albuquerque, NM · CIK 0001878989

Offering snapshot reported Jan 23, 2024 · SEC filing

Reported sold
$8.3M
Offering amount: $15M
Investors reported
9
Form D · investor count
Minimum accepted
$100K
Reported outside-investor minimum
First sale
Jan 11, 2024
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 23, 2024Initial$8,300,000No comparison9SEC filing
Mar 9, 2023Amendment$3,149,997$1,599,999vs Dec 9, 20217SEC filing
Dec 9, 2021Initial$1,549,998No comparison4SEC filing
Aug 20, 2021Initial$1,190,000No comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0 (estimated)
Finders' fees
$0 (estimated)
Form D file number
021-503219

Source: Form D, filed Jan 23, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
David Blivin Director
Joseph Cook Iii Director
Blivin David Director
Alexander Hafez Director, Executive, Promoter
Kosmas Karadimitriou Director
Stephen Mc Kernan Executive
Nikolaos Mellios Director
Cathy Petti Director
Fortunado Rocca Director
Paul Sargeant Director, Executive
Waneta Tuttle Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
5901 Indian School Rd Ne
Albuquerque, NM, 87110